Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MESA LABORATORIES INC /CO/MLAB · Entity 5221 | SVP Commercial | June 17, 2022 | June 22, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MESA LABORATORIES INC /CO/
Report date June 17, 2022 · Filed June 22, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,634 |
Ending reported balance
After 2022-06-21 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2022-06-17 · Exercise / conversion · Acquired 391 · Balance 3,084 Row 2 · 2022-06-17 · Tax withholding · Disposed 173 · Balance 2,911 F5: Represents shares of common stock received by Mesa Labs for tax withholding purposes in connection with the net-settlement of the issuance of shares of common stock in respect to the vested RSUs Row 3 · 2022-06-21 · Grant · Acquired 1,278 · Balance 4,189 F6: Shares represent common stock of Mesa Labs issued upon release of performance share units issued under the FY20-FY22 performance share unit program Row 4 · 2022-06-21 · Sale · Disposed 555 · Balance 3,634 F7: Shares sold to cover taxes associated with Performance Share Units |
| Restricted Stock Units - 1SEC Table II · derivative / convertible security | Direct | 90 |
Reported balance
After 2022-06-17 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-06-17 · Exercise / conversion · Disposed 90 · Balance 90 F1: Each RSU represents the contingent right to receive one share of the Issuer's common stock F2: RSUs that vest 1/5 on June 15, 2019 and each of the next four anniversary dates F3: Not Applicable |
| Restricted Stock Units - 2SEC Table II · derivative / convertible security | Direct | 300 |
Reported balance
After 2022-06-17 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-06-17 · Exercise / conversion · Disposed 301 · Balance 300 F1: Each RSU represents the contingent right to receive one share of the Issuer's common stock F4: RSUs that vest 1/3 on June 15, 2021 and each of the next two anniversary dates F3: Not Applicable |
Filing footnotes · ownership attribution and instrument terms
F1: Each RSU represents the contingent right to receive one share of the Issuer's common stock
F2: RSUs that vest 1/5 on June 15, 2019 and each of the next four anniversary dates
F3: Not Applicable
F4: RSUs that vest 1/3 on June 15, 2021 and each of the next two anniversary dates
F5: Represents shares of common stock received by Mesa Labs for tax withholding purposes in connection with the net-settlement of the issuance of shares of common stock in respect to the vested RSUs
F6: Shares represent common stock of Mesa Labs issued upon release of performance share units issued under the FY20-FY22 performance share unit program
F7: Shares sold to cover taxes associated with Performance Share Units
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 21, 2022 Filed Jun 22, 2022 18:04 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 555 | $188.22 | $104,464.32 |
DisclosureSEC source: 0001228924-22-000019 · primary_doc.xml · nonDerivative · entry 4 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,634 F7 · shares: Shares sold to cover taxes associated with Performance Share Units Read SEC document |
| June 21, 2022 Filed Jun 22, 2022 18:04 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantCommon Stock | 1,278 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000019 · primary_doc.xml · nonDerivative · entry 3 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,189 F6 · shares: Shares represent common stock of Mesa Labs issued upon release of performance share units issued under the FY20-FY22 performance share unit program Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 18:04 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 2 · Derivative | 301 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000019 · primary_doc.xml · derivative · entry 6 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 Underlying: Common Stock · 301 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents the contingent right to receive one share of the Issuer's common stock F4 · derivative.exercise_date: RSUs that vest 1/3 on June 15, 2021 and each of the next two anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 18:04 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 1 · Derivative | 90 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000019 · primary_doc.xml · derivative · entry 5 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90 Underlying: Common Stock · 90 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents the contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest 1/5 on June 15, 2019 and each of the next four anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 18:04 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Tax withholdingCommon Stock | 173 | $185.57 | $32,103.61 |
DisclosureSEC source: 0001228924-22-000019 · primary_doc.xml · nonDerivative · entry 2 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,911 F5 · shares: Represents shares of common stock received by Mesa Labs for tax withholding purposes in connection with the net-settlement of the issuance of shares of common stock in respect to the vested RSUs Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 18:04 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 391 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000019 · primary_doc.xml · nonDerivative · entry 1 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:52 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 6 · Derivative | 548 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000017 · primary_doc.xml · derivative · entry 1 DINOIA GREGORY · CIK 0001285581 · SVP Commerical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 548 Underlying: Common Stock · 548 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on June 30, 2022 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| November 08, 2021 Filed Nov 9, 2021 15:04 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 280 | $323.72 | $90,641.60 |
DisclosureSEC source: 0001228924-21-000076 · primary_doc.xml · nonDerivative · entry 1 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,693 Read SEC document |
| September 01, 2021 Filed Sep 1, 2021 23:53 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantNon Qualified Stock Options · Derivative | 3,223 | $0.00 Strike: $268.85 | $0.00 |
DisclosureSEC source: 0001228924-21-000071 · primary_doc.xml · derivative · entry 3 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,694 Underlying: Common Stock · 3,223 shares Expires 2027-09-01 F6 · derivative.exercise_date: NSOs that vest 1/3 on September 1, 2022, 1/3 on June 15, 2023 and 1/3 on June 15, 2024 Read SEC document |
| September 01, 2021 Filed Sep 1, 2021 23:53 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 5 · Derivative | 780 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000071 · primary_doc.xml · derivative · entry 2 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 780 Underlying: Common Stock · 780 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F4 · shares: RSUs granted for navigation of Company through Covid-19 F5 · derivative.exercise_date: RSUs that cliff vest on September 1, 2022 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| September 01, 2021 Filed Sep 1, 2021 23:53 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 4 · Derivative | 1,004 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000071 · primary_doc.xml · derivative · entry 1 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,004 Underlying: Common Stock · 1,004 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest 1/3 on September 1, 2022, 1/3 on June 15, 2023 and 1/3 on June 15, 2024 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 16:16 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 1,211 | $255.67 | $309,616.37 |
DisclosureSEC source: 0001228924-21-000039 · primary_doc.xml · nonDerivative · entry 2 DINOIA GREGORY · CIK 0001285581 · SVP Commericial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,973 F2 · shares: Shares sold to cover taxes associated with Performance Share Units Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:27 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Unit - 3 · Derivative | 559 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000034 · primary_doc.xml · derivative · entry 7 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 559 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive on e share of the Issuer's common stock F5 · derivative.exercise_date: Restricted Stock Units granted for 10% salary reduction for the twelve months ended May 31, 2021 and 60% of cash bonus target for Fiscal Year 2021 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:27 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Unit - 2 · Derivative | 310 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000034 · primary_doc.xml · derivative · entry 6 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 601 Underlying: Common Stock · 310 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive on e share of the Issuer's common stock F4 · derivative.exercise_date: Restricted Stock Units that vest 1/3 on June 15, 2021 and each of the next two anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:27 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 1 · Derivative | 90 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000034 · primary_doc.xml · derivative · entry 5 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180 Underlying: Common Stock · 90 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive on e share of the Issuer's common stock F2 · derivative.exercise_date: Restricted Stock Units that vest 1/5 on June 15, 2019 and each of the next four anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:27 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Tax withholdingCommon Stock | 415 | $263.30 | $109,269.50 |
DisclosureSEC source: 0001228924-21-000034 · primary_doc.xml · nonDerivative · entry 4 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,384 F6 · shares: Represents shares of common stock received by Mesa Labs for tax withholding purposes in connection with the net-settlement of the issuance of shares of common stock in respect to the vested RSUs. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:27 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 559 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000034 · primary_doc.xml · nonDerivative · entry 3 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:27 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 310 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000034 · primary_doc.xml · nonDerivative · entry 2 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,240 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:27 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 90 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000034 · primary_doc.xml · nonDerivative · entry 1 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 930 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 16:16 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantCommon Stock | 2,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000039 · primary_doc.xml · nonDerivative · entry 1 DINOIA GREGORY · CIK 0001285581 · SVP Commericial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,184 F1 · shares: Shares represent common stock of Mesa Labs issued upon release of performance share units issued under the FY2019-FY2021 performance share unit program Read SEC document |
| June 04, 2021 Filed Jun 7, 2021 17:19 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 540 | $0.00 Strike: $142.40 | $0.00 |
DisclosureSEC source: 0001228924-21-000022 · primary_doc.xml · derivative · entry 3 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,914 Underlying: Common Stock · 540 shares Expires 2024-04-02 F1 · derivative.exercise_date: 1/5 exercisable on each anniversary of the 4/2/18 grant date Read SEC document |
| June 04, 2021 Filed Jun 7, 2021 17:19 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 540 | $260.27 | $140,545.80 |
DisclosureSEC source: 0001228924-21-000022 · primary_doc.xml · nonDerivative · entry 2 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 840 Read SEC document |
| June 04, 2021 Filed Jun 7, 2021 17:19 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 540 | $142.40 | $76,896.00 |
DisclosureSEC source: 0001228924-21-000022 · primary_doc.xml · nonDerivative · entry 1 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,380 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2021 Filed Feb 24, 2021 15:47 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 280 | $276.75 | $77,490.00 |
DisclosureSEC source: 0001228924-21-000008 · primary_doc.xml · nonDerivative · entry 1 DINOIA GREGORY · CIK 0001285581 · SVP Commericial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 840 Read SEC document |
| October 02, 2020 Filed Oct 6, 2020 00:01 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 270 | $0.00 Strike: $142.40 | $0.00 |
DisclosureSEC source: 0001437749-20-020749 · rdgdoc.xml · derivative · entry 4 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,454 Underlying: Common Stock · 270 shares Expires 2024-04-02 F1 · derivative.exercise_date: 1/5 exercisable on each anniversary date of the 4/2/18 grant date Read SEC document |
| October 02, 2020 Filed Oct 6, 2020 00:01 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 62 | $260.00 | $16,120.00 |
DisclosureSEC source: 0001437749-20-020749 · rdgdoc.xml · nonDerivative · entry 3 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,120 F2 · kind: Sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2020 Read SEC document |
| October 02, 2020 Filed Oct 6, 2020 00:01 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 270 | $260.00 | $70,200.00 |
DisclosureSEC source: 0001437749-20-020749 · rdgdoc.xml · nonDerivative · entry 2 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,182 F2 · kind: Sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2020 Read SEC document |
| October 02, 2020 Filed Oct 6, 2020 00:01 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 270 | $142.40 | $38,448.00 |
DisclosureSEC source: 0001437749-20-020749 · rdgdoc.xml · nonDerivative · entry 1 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 16:08 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 280 | $243.55 | $68,194.00 |
DisclosureSEC source: 0001228924-20-000026 · primary_doc.xml · nonDerivative · entry 1 DINOIA GREGORY · CIK 0001285581 · SVP Commerical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,182 Read SEC document |
| August 17, 2020 Filed Aug 18, 2020 21:20 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 783 | $0.00 Strike: $203.54 | $0.00 |
DisclosureSEC source: 0001228924-20-000022 · primary_doc.xml · derivative · entry 3 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,724 Underlying: Common Stock · 783 shares Expires 2025-06-10 F1 · derivative.exercise_date: 1/4 exercisable on each anniversary date of the 6-10-19 grant date Read SEC document |
| August 17, 2020 Filed Aug 18, 2020 21:20 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 835 | $245.70 | $205,159.50 |
DisclosureSEC source: 0001228924-20-000022 · primary_doc.xml · nonDerivative · entry 2 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,462 Read SEC document |
| August 17, 2020 Filed Aug 18, 2020 21:20 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 783 | $203.54 | $159,371.82 |
DisclosureSEC source: 0001228924-20-000022 · primary_doc.xml · nonDerivative · entry 1 DINOIA GREGORY · CIK 0001285581 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 16:59 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 3 · Derivative | 559 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000019 · primary_doc.xml · derivative · entry 6 DINOIA GREGORY · CIK 0001285581 · SVP Commecial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 559 Underlying: Common Stock · 559 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F7 · shares: RSUs granted for 10% salary reduction for 12 months and conversion of 60% of cash bonus target for Fiscal Year 21 F8 · derivative.exercise_date: RSUs that cliff vest on June 15, 2021 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 16:59 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantNon Qualified Stock Options · Derivative | 3,026 | $0.00 Strike: $226.72 | $0.00 |
DisclosureSEC source: 0001228924-20-000019 · primary_doc.xml · derivative · entry 5 DINOIA GREGORY · CIK 0001285581 · SVP Commecial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,507 Underlying: Common Stock · 3,026 shares Expires 2026-06-15 F6 · derivative.exercise_date: NSOs that vest approximately 1/3 on June 30, 2021 and each of the next two anniversary dates Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 16:59 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 2 · Derivative | 911 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000019 · primary_doc.xml · derivative · entry 4 DINOIA GREGORY · CIK 0001285581 · SVP Commecial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 911 Underlying: Common Stock · 911 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F5 · derivative.exercise_date: RSUs that vest approximately 1/3 on June 15, 2021 and each of the next two anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 16:59 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 1 · Derivative | 90 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000019 · primary_doc.xml · derivative · entry 3 DINOIA GREGORY · CIK 0001285581 · SVP Commecial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270 Underlying: Common Stock · 90 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest 1/5 on June 15, 2019 and each of the next four anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 16:59 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Tax withholdingCommon Stock | 38 | $226.72 | $8,615.36 |
DisclosureSEC source: 0001228924-20-000019 · primary_doc.xml · nonDerivative · entry 2 DINOIA GREGORY · CIK 0001285581 · SVP Commecial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,514 F4 · shares: Represents shares of common stock retained by Mesa Labs for tax withholding purposes in connection with the net-settlement on the issuance of shares of common stock in respect to vested RSUs Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 16:59 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 90 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000019 · primary_doc.xml · nonDerivative · entry 1 DINOIA GREGORY · CIK 0001285581 · SVP Commecial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,552 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2019 Filed Jun 18, 2019 17:21 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Unit - 1 · Derivative | 90 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000031 · primary_doc.xml · derivative · entry 3 DINOIA GREGORY · CIK 0001285581 · SVP Commerical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360 Underlying: Common Stock · 90 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Restricted Stock Units that vest 1/5 on June 15, 2019 and each of the next four June 15's thereafter F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2019 Filed Jun 18, 2019 17:21 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Tax withholdingCommon Stock | 28 | $202.39 | $5,666.92 |
DisclosureSEC source: 0001228924-19-000031 · primary_doc.xml · nonDerivative · entry 2 DINOIA GREGORY · CIK 0001285581 · SVP Commerical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,462 Read SEC document |
| June 15, 2019 Filed Jun 18, 2019 17:21 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 90 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000031 · primary_doc.xml · nonDerivative · entry 1 DINOIA GREGORY · CIK 0001285581 · SVP Commerical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2019 Filed Jun 13, 2019 15:15 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantNon-Qualified Stock Option · Derivative | 3,131 | $0.00 Strike: $203.54 | $0.00 |
DisclosureSEC source: 0001228924-19-000017 · primary_doc.xml · derivative · entry 1 DINOIA GREGORY · CIK 0001285581 · SVP Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,481 Underlying: Common Stock · 3,131 shares Expires 2025-06-10 F1 · derivative.exercise_date: 1/4 exercisable on each of first 4 anniversary dates Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.